Literature Collection

Collection Insights

11K+

References

9K+

Articles

1400+

Grey Literature

4600+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Year
Sort by
Order
Show
11231 Results
10541
Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings
Type: Journal Article
Authors: M. C. Frost, E. M. Soyer, C. E. Achtmeyer, E. J. Hawkins, J. E. Glass, K. A. Hallgren, E. C. Williams
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
,
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
10542
Treating pain in addicted patients: recommendations from an expert panel
Type: Journal Article
Authors: M. Cheatle, D. Comer, M. Wunsch, A. Skoufalos, Y. Reddy
Year: 2014
Publication Place: United States
Abstract: Clinicians may face pragmatic, ethical, and legal issues when treating addicted patients. Equal pressures exist for clinicians to always address the health care needs of these patients in addition to their addiction. Although controversial, mainly because of the lack of evidence regarding their long-term efficacy, the use of opioids for the treatment of chronic pain management is widespread. Their use for pain management in the addicted population can present even more challenges, especially when evaluating the likelihood of drug-seeking behavior. As the misuse and abuse of opioids continues to burgeon, clinicians must be particularly vigilant when prescribing chronic opioid therapy. The purpose of this article is to summarize recommendations from a recent meeting of experts convened to recommend how primary care physicians should approach treatment of chronic pain for addicted patients when an addiction specialist is not available for a referral. As there is a significant gap in guidelines and recommendations in this specific area of care, this article serves to create a foundation for expanding chronic pain guidelines in the area of treating the addicted population. This summary is designed to be a practical how-to guide for primary care physicians, discussing risk assessment, patient stratification, and recommended therapeutic approaches.
Topic(s):
Opioids & Substance Use See topic collection
,
Education & Workforce See topic collection
10543
Treating Pain in an Established Patient: Sifting Through the Guidelines
Type: Journal Article
Authors: A. L. Gordon, S. L. Connolly
Year: 2017
Publication Place: United States
Abstract: The CDC Guideline for Prescribing Opioids for Chronic Pain, published last March, provided major steps toward bringing the medical community together to address the opioid epidemic in the U.S. However, the Guideline focuses primarily on treatment of new inductions into opioid therapy for pain. Physicians may have difficulty figuring out how to apply the CDC's recommendations to patients who are already receiving opioid maintenance therapy for chronic pain. Patients already maintained on opioids for chronic pain should not be subjected to abrupt cessation or rapid tapers, and the CDC's Guideline confirms this. Physicians should not balk from treating opioid-dependent patients with chronic pain, and the CDC's recommendations do contain helpful information if one reads through them carefully. This article attempts to distill the major points from the Guideline for the treatment of chronic-pain patients already on long-term opioid therapy.[Full article available at http://rimed.org/rimedicaljournal-2017-10.asp].
Topic(s):
Opioids & Substance Use See topic collection
10544
Treating Pain in an Established Patient: Sifting Through the Guidelines
Type: Journal Article
Authors: A. L. Gordon, S. L. Connolly
Year: 2017
Publication Place: United States
Abstract: The CDC Guideline for Prescribing Opioids for Chronic Pain, published last March, provided major steps toward bringing the medical community together to address the opioid epidemic in the U.S. However, the Guideline focuses primarily on treatment of new inductions into opioid therapy for pain. Physicians may have difficulty figuring out how to apply the CDC's recommendations to patients who are already receiving opioid maintenance therapy for chronic pain. Patients already maintained on opioids for chronic pain should not be subjected to abrupt cessation or rapid tapers, and the CDC's Guideline confirms this. Physicians should not balk from treating opioid-dependent patients with chronic pain, and the CDC's recommendations do contain helpful information if one reads through them carefully. This article attempts to distill the major points from the Guideline for the treatment of chronic-pain patients already on long-term opioid therapy.[Full article available at http://rimed.org/rimedicaljournal-2017-10.asp].
Topic(s):
Opioids & Substance Use See topic collection
10546
Treating patients with functional somatic symptoms. A treatment guide for use in general practice
Type: Journal Article
Authors: K. Fritzsche, A. Larisch
Year: 2003
Publication Place: Norway
Abstract: Patients who experience body symptoms in response to psychosocial stress are a challenge for the general practitioner (GP). This paper is a contribution to the improved treatment of these patients. It presents a specific psychosocial treatment model provided by the GP including the following steps: (a) taking a thorough symptom history, conducting a psychosocial anamnesis and exploring the patient's own perception of the illness, (b) developing alternative perceptions of the illness by understanding the psycho-physiological relationship; and (c) reducing the impact of psychosocial stress. The application of these specific techniques requires a trustful, helping alliance between the doctor and the patient and cooperation with mental health services.
Topic(s):
Medically Unexplained Symptoms See topic collection
10547
Treating patients with medically unexplained symptoms in primary care
Type: Journal Article
Authors: R. C. Smith, C. Lein, C. Collins, J. S. Lyles, B. Given, F. C. Dwamena, J. Coffey, A. Hodges, J. C. Gardiner, J. Goddeeris, C. W. Given
Year: 2003
Publication Place: United States
Abstract: BACKGROUND: There are no proven, comprehensive treatments in primary care for patients with medically unexplained symptoms (MUS) even though these patients have high levels of psychosocial distress, medical disability, costs, and utilization. Despite extensive care, these common patients often become worse. OBJECTIVE: We sought to identify an effective, research-based treatment that can be conducted by primary care personnel. DESIGN: We used our own experiences and files, consulted with experts, and conducted an extensive review of the literature to identify two things: 1). effective treatments from randomized controlled trials for MUS patients in primary care and in specialty settings; and 2). any type of treatment study in a related area that might inform primary care treatment, for example, depression, provider-patient relationship. MAIN RESULTS: We developed a multidimensional treatment plan by integrating several areas of the literature: collaborative/stepped care, cognitive-behavioral treatment, and the provider-patient relationship. The treatment is designed for primary care personnel (physicians, physician assistants, nurse practitioners) and deployed intensively at the outset; visit intervals are progressively increased as stability and improvement occur. CONCLUSION: Providing a comprehensive treatment plan for chronic, high-utilizing MUS patients removes one barrier to treating this common problem effectively in primary care by primary care personnel.
Topic(s):
Medically Unexplained Symptoms See topic collection
10548
Treating patients with multiple substance use in accordance with their personal treatment goals: a new paradigm for addiction treatment
Type: Journal Article
Authors: Joachim Körkel
Year: 2021
Publication Place: Brighton
Topic(s):
Education & Workforce See topic collection
,
Opioids & Substance Use See topic collection
10550
Treating post-traumatic stress disorder with a prolonged exposure protocol within primary care behavioral health: A case example
Type: Journal Article
Authors: Stacy A. Ogbeide, Alex Young, Brittany Houston, Cory Knight
Year: 2020
Topic(s):
Financing & Sustainability See topic collection
,
Healthcare Disparities See topic collection
,
Measures See topic collection
10551
Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates
Type: Journal Article
Authors: Bernadette Winklbaur, Nina Kopf, Nina Ebner, Erika Jung, Kenneth Thau, Gabriele Fischer
Year: 2008
Topic(s):
Opioids & Substance Use See topic collection
10552
Treating subthreshold depression in primary care: A randomized controlled trial of behavioral activation with mindfulness
Type: Journal Article
Authors: Samuel Y. S. Wong, Yu Ying Sun, Aaroy T. Y. Chan, Maria K. W. Leung, David V. K. Chao, Carole C. K. Li, King K. H. Chan, Wai Kwong Tang, Trevor Mazzucchelli, Alma M. L. Au, Benjamin H. K. Yip
Year: 2018
Topic(s):
Healthcare Disparities See topic collection
,
Measures See topic collection
10553
Treating the Rural Opioid Epidemic
Type: Report
Authors: Christine Hancock, Heidi Mennenga, Nikki King, Holly Andrilla, Eric Larson, Pat Schou
Year: 2017
Topic(s):
Grey Literature See topic collection
,
Financing & Sustainability See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

10554
Treating Tobacco Use Disorder in Pregnant Women in Medication-Assisted Treatment for an Opioid Use Disorder: A Systematic Review
Type: Journal Article
Authors: Sarah C. Akerman, Mary F. Brunette, Alan I. Green, Daisy J. Goodman, Heather B. Blunt, Sarah H. Heil
Year: 2015
Publication Place: Elmsford
Topic(s):
Opioids & Substance Use See topic collection
10555
Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance
Type: Journal Article
Authors: S. L. Klaman, K. Isaacs, A. Leopold, J. Perpich, S. Hayashi, J. Vender, M. Campopiano, H. E. Jones
Year: 2017
Publication Place: United States
Abstract: OBJECTIVES: The prevalence of opioid use disorder (OUD) during pregnancy is increasing. Practical recommendations will help providers treat pregnant women with OUD and reduce potentially negative health consequences for mother, fetus, and child. This article summarizes the literature review conducted using the RAND/University of California, Los Angeles Appropriateness Method project completed by the US Department of Health and Human Services Substance Abuse and Mental Health Services Administration to obtain current evidence on treatment approaches for pregnant and parenting women with OUD and their infants and children. METHODS: Three separate search methods were employed to identify peer-reviewed journal articles providing evidence on treatment methods for women with OUD who are pregnant or parenting, and for their children. Identified articles were reviewed for inclusion per study guidelines and relevant information was abstracted and summarized. RESULTS: Of the 1697 articles identified, 75 were included in the literature review. The perinatal use of medication for addiction treatment (MAT, also known as medication-assisted treatment), either methadone or buprenorphine, within comprehensive treatment is the most accepted clinical practice, as withdrawal or detoxification risks relapse and treatment dropout. Medication increases may be needed with advancing pregnancy, and are not associated with more severe neonatal abstinence syndrome (NAS). Switching medication prenatally is usually not recommended as it can destabilize opioid abstinence. Postnatally, breastfeeding is seen as beneficial for the infant for women who are maintained on a stable dose of opioid agonist medication. Less is known about ideal pain management and postpartum dosing regimens. NAS appears generally less severe following prenatal exposure to buprenorphine versus methadone. Frontline NAS medication treatments include protocol-driven methadone and morphine dosing in the context of nonpharmacological supports. CONCLUSIONS: Women with OUD can be treated with methadone or buprenorphine during pregnancy. NAS is an expected and manageable condition. Although research has substantially advanced, opportunities to guide future research to improve maternal and infant outcomes are provided.
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
10557
Treatment access for opioid use disorder among women with medicaid in Florida
Type: Journal Article
Authors: A. L. Elmore, S. W. Patrick, E. McNeer, K. Fryer, C. N. Reid, W. M. Sappenfield, S. Mehra, J. L. Salemi, J. Marshall
Year: 2023
10558
Treatment access for opioid use disorder in pregnancy among rural and American Indian communities
Type: Journal Article
Authors: Taylor Kelley, Marcela C. Smid, Jacob D. Baylis, Elizabeth Charron, Lori Jo Begaye, Amy Binns-Calvey, Shayla Archer, Saul Weiner, Warren Pettey, Gerald Cochran
Year: 2022
Topic(s):
Opioids & Substance Use See topic collection
,
Education & Workforce See topic collection
10559
Treatment access for opioid use disorder in pregnancy among rural and American Indian communities
Type: Journal Article
Authors: A. T. Kelley, M. C. Smid, J. D. Baylis, E. Charron, L. J. Begaye, A. Binns-Calvey, S. Archer, S. Weiner, W. Pettey, G. Cochran
Year: 2022
Publication Place: United States
Abstract:

BACKGROUND: Opioid use disorder (OUD) in pregnancy disproportionately impacts rural and American Indian (AI) communities. With limited data available about access to care for these populations, this study's objective was to assess clinic knowledge and new patient access for OUD treatment in three rural U.S. counties. MATERIAL AND METHODS: The research team used unannounced standardized patients (USPs) to request new patient appointments by phone for white and AI pregnant individuals with OUD at primary care and OB/GYN clinics that provide prenatal care in three rural Utah counties. We assessed a) clinic familiarity with buprenorphine for OUD; b) appointment availability for buprenorphine treatment; c) appointment wait times; d) referral provision when care was unavailable; and e) availability of OUD care at referral locations. We compared outcomes for AI and white USP profiles using descriptive statistics. RESULTS: The USPs made 34 calls to 17 clinics, including 4 with publicly listed buprenorphine prescribers on the Substance Abuse and Mental Health Services Administration website. Among clinical staff answering calls, 16 (47%) were unfamiliar with buprenorphine. OUD treatment was offered when requested in 6 calls (17.6%), with a median appointment wait time of 2.5 days (IQR 1-5). Among clinics with a listed buprenorphine prescriber, 2 of 4 (50%) offered OUD treatment. Most clinics (n = 24/28, 85.7%) not offering OUD treatment provided a referral; however, a buprenorphine provider was unavailable/unreachable 67% of the time. The study observed no differences in appointment availability between AI and white individuals. CONCLUSIONS: Rural-dwelling AI and white pregnant individuals with OUD experience significant barriers to accessing care. Improving OUD knowledge and referral practices among rural clinics may increase access to care for this high-risk population.

Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
10560
Treatment access for opioid use disorder in pregnancy among rural and American Indian communities
Type: Journal Article
Authors: A. T. Kelley, Marcela C. Smid, Jacob D. Baylis, Elizabeth Charron, Lori Jo Begaye, Amy Binns-Calvey, Shayla Archer, Saul Weiner, Warren Pettey, Gerald Cochran
Year: 2021
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection